(Q51473115)

5 April 2018

editorial

0 references

title

The Global Emergence of Unregulated Stem Cell Treatments for Respiratory Diseases. Professional Societies Need to Act. (English)

1 reference

5 April 2018

author

Robert J. Freishtat

2

1 reference

5 April 2018

Darcy E. Wagner

3

1 reference

5 April 2018

Laertis Ikonomou

object named as

Laertis Ikonomou

Angela Panoskaltsis-Mortari

1

0 references

4

object named as

Angela Panoskaltsis-Mortari

1 reference

5 April 2018

Daniel J Weiss

5

1 reference

5 April 2018

publication date

1 August 2016

1 reference

5 April 2018

Proceedings of the American Thoracic Society

published in

1 reference

5 April 2018

volume

13

1 reference

5 April 2018

issue

8

1 reference

5 April 2018

page(s)

1205-1207

1 reference

5 April 2018

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient

cites work

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

US stem cell clinics, patient safety, and the FDA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

On the Road (to a Cure?)--Stem-Cell Tourism and Lessons for Gene Editing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

Hope, hype and help: ethically assessing the growing market in stem cell therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

Therapeutic hope, spiritual distress, and the problem of stem cell tourism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

Stem cell hype: media portrayal of therapy translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

Medicine's Wild West--Unlicensed Stem-Cell Clinics in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

Patients Beware: Commercialized Stem Cell Treatments on the Web

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

Stem cells: Taking a stand against pseudoscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

Chinese newspaper coverage of (unproven) stem cell therapies and their providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

Risk and the Black American child: representations of children’s mental health issues in three popular African American magazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

FDA’s claims over stem cells upheld

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201604-277ED

10.1513/ANNALSATS.201604-277ED

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018